Literature DB >> 2186954

Gallbladder stone fragments in feces after biliary extracorporeal shock-wave lithotripsy.

L Greiner1, C Münks, W Heil, C Jakobeit.   

Abstract

All stools passed on the first 3 days after extracorporeal shock-wave lithotripsy of gallbladder stones in 21 patients were collected and examined for the presence of stone fragments. A total of 555 fragments varying in number per patient (4-69) and in size (maximum diameters from 0.5-8.0 mm) were recovered by sieving aqueous suspensions of the feces. All 482 fragments less than or equal to 3.0 mm left the biliary tract without any clinical symptoms, as did the three largest fragments with maximum diameters of 7.0-8.0 mm and almost all of the 70 fragments measuring 3.5-5.0 mm. During the observation period, four episodes of biliary complaints were recorded in three patients in whom fragments with maximum diameters of 3.5-5.0 mm were found. The only chemical abnormality was a temporary elevation of lipase activity to twice the normal range in 1 case. All fragments were identified as gallbladder stones by infrared spectroscopy on the basis of their (varyingly high) cholesterol content. By macroscopic criteria, most of the fragments were from mixed stones; therefore, provided there is a functioning gallbladder and sufficiently fine fragmentation, successful extracorporeal shock-wave lithotripsy does not seem to be limited to pure cholesterol stones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186954     DOI: 10.1016/0016-5085(90)91099-r

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

Review 1.  Management of suspected stones in the common bile duct.

Authors:  Majid A Almadi; Jeffrey S Barkun; Alan N Barkun
Journal:  CMAJ       Date:  2012-04-16       Impact factor: 8.262

2.  Repeated piezoelectric lithotripsy for gallstones with and without ursodeoxycholic acid dissolution: a multicenter study.

Authors:  Y Tsuchiya; F Ishihara; G Kajiyama; S Nakazawa; M Otho; H Tanimura; Y Akura; M Harada; M Hihara; Y Kawai
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

3.  ESWL experience in the therapy of difficult bile duct stones.

Authors:  D Lomanto; F Fiocca; M Nardovino; E Grasso; E Lezoche; E Zarba Meli; A Paganini; V Speranza
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Sphincter of Oddi dysfunction after successful gallstone lithotripsy (postlithotripsy syndrome): manometric data and results of endoscopic sphincterotomy.

Authors:  T Wehrmann; B Lembcke; W F Caspary; H Seifert
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

5.  Single-stage laparoscopic treatment of gallstones and common bile duct stones in 120 unselected, consecutive patients.

Authors:  E Lezoche; A M Paganini
Journal:  Surg Endosc       Date:  1995-10       Impact factor: 4.584

6.  Laparoscopic treatment of gallbladder and common bile duct stones: a prospective study.

Authors:  E Lezoche; A M Paganini; F Carlei; F Feliciotti; D Lomanto; M Guerrieri
Journal:  World J Surg       Date:  1996-06       Impact factor: 3.352

7.  Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.

Authors:  M Boscaini; M Piccinni-Leopardi; F Andreotti; A Montori
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  ESWL and oral dissolution therapy. What factors influence results?

Authors:  A Buttmann; H E Adamek; J Weber; J F Riemann
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

9.  Pulverisation of calcified and non-calcified gall bladder stones: extracorporeal shock wave lithotripsy used alone.

Authors:  N Soehendra; V C Nam; K F Binmoeller; H Koch; S Bohnacker; H W Schreiber
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

10.  Relationship between cystic duct diameter and the presence of cholelithiasis.

Authors:  M Castelain; C Grimaldi; A G Harris; F X Caroli-Bosc; P Hastier; R Dumas; J P Delmont
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.